Review of known prognostic variables

Area of Science:

• Oncology
• Medical Research

Background:

• Patient prognosis in primary breast cancer is influenced by prognostic factors and treatment efficacy.
• Systemic adjuvant therapy benefits are modest in specific patient subgroups, necessitating precise patient selection.
• Identifying patients with very good or very poor prognoses is essential for tailoring treatment strategies.

Purpose of the Study:

• To emphasize the necessity of proper patient selection for primary breast cancer treatment.
• To highlight key prognostic factors for classifying patients into very good or very poor prognosis groups.
• To guide treatment decisions based on prognostic and predictive variables.

Main Methods:

• Classification of patients based on established prognostic factors: tumor size (T), grade, hormone receptor status, age, and S-phase fraction.
• Utilizing tumor size as the primary factor for treatment decisions (surgery, preoperative, or adjuvant therapy).
• Referencing a table (Table 4) for treatment decisions based on prognostic and predictive variables.

Main Results:

• Patients with very good prognosis exhibit small tumors (T ≤ 1 cm), grade 1, and hormone receptor-positive status.
• Patients with very poor prognosis are characterized by young age (< 35 years), large tumors (T > 3 cm), grade 3, hormone receptor-negative status, and high S-phase fractions.
• Tumor size is identified as the most significant prognostic factor for guiding treatment decisions.

Conclusions:

• Treatment decisions for primary breast cancer should be based on comprehensive prognostic and predictive information, especially outside clinical trials.
• Adjuvant systemic treatment intensity should be guided by tumor receptor status, patient age, and menopausal status.
• Further research is needed to define prognosticators for the metastatic potential of breast cancer cells.